Trial intelligence / Profile preview

INSIGHT: Tolvaptan in Elderly Hyponatremia

NCT00550459Phase 3Completed

Sponsor
Otsuka Pharmaceutical Development & Commercialization
Start
Aug 2007
Primary completion
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tolvaptan in hyponatremia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Aug 2007; status: completed.

02

Drugs

tolvaptan
03

Conditions

hyponatremia

Beyond the preview

Go deeper on NCT00550459.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00550459.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call